Starting early for today's visits for research labs, my baseline bone marrow aspirate, and meeting with the trial NP to acquire my medications for the next 28 days.
“Choosing to have joy is not naively thinking everything will be easy. It is courageously believing that there is still hope, even when things get hard.” – Morgan Harper Nichols
Starting early for today's visits for research labs, my baseline bone marrow aspirate, and meeting with the trial NP to acquire my medications for the next 28 days.
My mom had a great idea to get away to the beach today. We went to Atlantic City and Margate City, NJ.
This is what I felt like yesterday.
You would think I would have learned this lesson by now, but apparently I have not. I was tossed a major curve ball when meeting with the ABBY clinical team today. First the clinical trial research coordinator and Fellow (student doctor) came in. The clinical trial research coordinator asked me if I had any questions which was fair. I asked my prepared questions and we continued. Next the Fellow asked me what I knew about the trial. Having read the consent and all other materials sent, I sat, with tall shoulders and a proud chest, and with all my confidence, told her what I knew.
She then looked at me and said, "Are you aware you have to come back to Philadelphia every month for in in-person evaluation and to get your medications for this trial?"
There's nothing like staying up for 21 hours and changing 3 time zones. 14 hours of sleep and a shower later, today was a good day.
We ventured to the Philadelphia Zoo and spent the beautiful day wandering around the animals. Something that is a little more intentional these days is recognizing a good day. The sun was shining, the weather was warm, but not hot, and...
ABBY is a Stage II clinical trial:
Today is my packing day in preparation of heading to the airport this evening. It wasn't until today that I could mentally prepare for this trip. I find myself much more relaxed in anticipation of a flight. I'll pack what I pack and I'll make my flight. No more amping up and worrying about flying.
Working on...I found this emotions wheel from BEAM, and loved the messiness of it. It's not just this perfect circle with perfect colors. It's alive.
My most succinct answer is: It's both. It's why I did this (SURMOUNT) clinical trial. I'm catching potential future cancer cells before they have a chance to attach to an organ and become metastatic if the study (ABBY) medication(s) work as intended. It's bad that I have them though as it greatly increases my risk of metastatic cancer if we can't kill them with these study (ABBY) medication(s). Makes my approach proactive and not just reactive. The current practice without clinical trials is waiting to treat it until it has metastasized.
The words I've used to some is "scientifically inevitable". Let us remember I have triple positive breast cancer which is HER2+ and HR+ and I had a residual cancer burden (or not a pathologic completed response) after chemotherapy prior to surgery (neoadjuvant).
Let us consider:
First 5 Years: HER2-positive (HER2+) recurrences most commonly appear within the first five years, often peaking around 20 months to 3 years after diagnosis.
Beyond 5 Years: Because of the hormone receptor-positive (HR+) component, patients carry a steady, persistent long-term risk of late recurrence that can extend past 5 to 10 years post-surgery.
Other Risk Factors:
Other Considerations:
Site of recurrence: If it returns as metastatic (distant) disease, HER2-positive (HER2+) cancer has a higher tendency to recur in the brain compared to some other subtypes.
Let us remember, this is why I chose to enter these clinical trials, so others may live.
I realized I never posted about the end of our trip to Philadelphia. We were able to take some time to explore our nations history at Valley Forge and exploring the Independence National Park area. We made it home in one piece.
This void was due to a time of waiting, a time of pause. But when I got my call from my SURMOUNT clinical trial investigator on August 26th with the results of my bone marrow aspirate, we were quickly launched back in to go mode.
This bone marrow aspirate showed 1 disseminated tumor cell in 10 slides and was confirmed by a second pathologist to prevent false positive. As posted in the past, bone marrow aspirates for this purpose began with a 40% chance of false negative, so finding a confirmed positive disseminated tumor cell on the 2nd bone marrow aspirate was, in a way, lucky.
A couple links to a refresher on the trials and what these words mean: https://saolgairegra.blogspot.com/2025/10/entering-world-of-clinical-trials.html
https://saolgairegra.blogspot.com/2026/02/surmount-clinical-trail-results-from.html
I received a call within 1 hour of my results from the SURMOUNT Trial to enroll in the ABBY Trial. They requested that I return to Philadelphia as of September 8th to start the consent and lab draws and remain there until September 10th to obtain a baseline bone marrow aspirate and complete randomization to see which arm of the trial I will have for treatment.
I heard this song driving into Philly and found it apropos:
At the Perelman Center, ready for my labs and bone marrow aspirate!